Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$17.84 +0.06 (+0.34%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$17.69 -0.15 (-0.86%)
As of 10/9/2026 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

FBIOP vs. SXTPW, BFRIW, CALA, CINGW, and CLVR

Should you buy Fortress Biotech stock or one of its competitors? Fortress Biotech's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Clever Leaves (CLVR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Fortress Biotech compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Fortress Biotech. MarketBeat recorded 4 mentions for 60 Degrees Pharmaceuticals and 2 mentions for Fortress Biotech. 60 Degrees Pharmaceuticals' average media sentiment score of 1.19 beat Fortress Biotech's score of 0.02 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Positive
Fortress Biotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Fortress Biotech on 2 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Biofrontera?

Fortress Biotech (NASDAQ:FBIOP) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Fortress Biotech and Fortress Biotech both had 2 articles in the media. Biofrontera's average media sentiment score of 0.91 beat Fortress Biotech's score of 0.02 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Fortress Biotech Neutral
Biofrontera Positive

Summary

Fortress Biotech and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Calithera Biosciences?

Fortress Biotech (NASDAQ:FBIOP) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Fortress Biotech has higher revenue and earnings than Calithera Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Calithera Biosciences N/A N/A N/A

In the previous week, Fortress Biotech had 1 more articles in the media than Calithera Biosciences. MarketBeat recorded 2 mentions for Fortress Biotech and 1 mentions for Calithera Biosciences. Calithera Biosciences' average media sentiment score of 0.67 beat Fortress Biotech's score of 0.02 indicating that Calithera Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Fortress Biotech Neutral
Calithera Biosciences Positive

Summary

Fortress Biotech beats Calithera Biosciences on 2 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Cingulate?

Fortress Biotech (NASDAQ:FBIOP) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Fortress Biotech and Fortress Biotech both had 2 articles in the media. Cingulate's average media sentiment score of 1.41 beat Fortress Biotech's score of 0.02 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Fortress Biotech Neutral
Cingulate Positive

Summary

Fortress Biotech and Cingulate tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

Fortress Biotech has higher revenue and earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$7.56N/A
Fortress Biotech$68.47MN/AN/AN/AN/A

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
Fortress Biotech N/A N/A N/A

In the previous week, Fortress Biotech had 2 more articles in the media than Clever Leaves. MarketBeat recorded 2 mentions for Fortress Biotech and 0 mentions for Clever Leaves. Fortress Biotech's average media sentiment score of 0.02 beat Clever Leaves' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Clever Leaves Neutral
Fortress Biotech Neutral

Summary

Fortress Biotech beats Clever Leaves on 3 of the 5 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.43B$7.26B$13.29B
Dividend Yield12.11%2.63%2.52%22.58%
P/E RatioN/A800.13275.2826.14
Price / SalesN/A746.43582.3887.87
Price / CashN/A15.2827.3036.12
Price / BookN/A9.1510.826.16
Net IncomeN/A$2.84B$3.50B$381.12M
7 Day Performance6.16%-0.94%-0.89%-1.40%
1 Month Performance-3.31%-3.67%-4.02%-3.35%
1 Year Performance149.86%-3.97%7.13%1.49%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$17.84
+0.3%		N/A+149.9%$0.00$68.47MN/A78
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
flat		N/A-42.9%$0.00$1.11MN/A3
BFRIW
Biofrontera
N/A$0.01
-21.0%		N/A-94.5%$0.00$46.18MN/A94
CALA
Calithera Biosciences
N/A$0.00
flat		N/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
flat		N/AN/A$0.00N/AN/A14

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel